Fatigue and health-related quality of life in patients with immune thrombocytopenia: a longitudinal assessment in China

被引:0
作者
Zhang, Wenhui [1 ,2 ]
Xie, Shitong [3 ,4 ]
Fu, Rongfeng [1 ]
Chen, Yunfei [1 ]
Liu, Wei [1 ]
Sun, Ting [1 ]
Ju, Mankai [1 ]
Li, Huiyuan [1 ]
Xue, Feng [1 ]
Zhang, Lei [1 ]
Liu, Xiaofan [1 ,5 ,6 ]
Yang, Renchi [1 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol & Blood Dis Hosp, Haihe Lab Cell Ecosyst, Natl Clin Res Ctr Blood Dis,State Key Lab Expt Hem, Tianjin, Peoples R China
[2] Qingdao Univ, Dept Hematol, Affiliated Hosp, Qingdao, Peoples R China
[3] Tianjin Univ, Sch Pharmaceut Sci & Technol, Tianjin, Peoples R China
[4] Tianjin Univ, Ctr Social Sci Survey & Data, Tianjin, Peoples R China
[5] Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol & Blood Dis Hosp, State Key Lab Expt Hematol, Natl Clin Res Ctr Blood Dis,Haihe Lab Cell Ecosyst, Tianjin 300020, Peoples R China
[6] Tianjin Inst Hlth Sci, Tianjin 301600, Peoples R China
基金
中国国家自然科学基金;
关键词
Immune thrombocytopenia; HRQoL; FACIT-F; ITP-PAQ; longitudinal; PURPURA; MANAGEMENT; CANCER; ADULTS; COST;
D O I
10.1080/17474086.2023.2286730
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundThere is lacking studies of longitudinally assessment of fatigue and health-related quality of life (HRQoL) among Chinese immune thrombocytopenia (ITP) adults. We aimed to evaluate changes in fatigue and HRQoL and identify the associated factors.MethodsPatients' characteristics, Functional Assessment of Chronic Illness Therapy (FACIT-F) and the ITP-specific Patient Assessment Questionnaire (ITP-PAQ) scores at admission (T0), at discharge (T1), and three months after discharge (T2) were collected. Linear mixed effects models were used to examine changes over time.ResultsWe included 175 patients. The mean score of FACIT-F at T0 was 37.2 and increased at T1 (39.0), while then decreased at T2 (34.7). Patients who were single, retired, had persistent ITP, splenomegaly had more severe fatigue, whereas those who had not received any prior treatment and had a bleeding score of 0 at admission had milder fatigue. The mean score of ITP-PAQ was 57.7 at T0, then gradually increased to 60.3 at T1 and 62.8 at T2. Patients with persistent ITP and those who have never received treatment for ITP have better HRQoL.ConclusionITP adults' fatigue and HRQoL were impaired. Patients' fatigue improved at discharge but worsened at three months after discharge, while HRQoL gradually improved over time.
引用
收藏
页码:1125 / 1133
页数:9
相关论文
共 33 条
  • [1] Pathogenesis of immune thrombocytopenia
    Audia, Sylvain
    Mahevas, Matthieu
    Samson, Maxime
    Godeau, Bertrand
    Bonnotte, Bernard
    [J]. AUTOIMMUNITY REVIEWS, 2017, 16 (06) : 620 - 632
  • [2] China blood, US
  • [3] Immune thrombocytopenia (ITP) World Impact Survey (I-WISh): Impact of ITP on health-related quality of life
    Cooper, Nichola
    Kruse, Alexandra
    Kruse, Caroline
    Watson, Shirley
    Morgan, Mervyn
    Provan, Drew
    Ghanima, Waleed
    Arnold, Donald M.
    Tomiyama, Yoshiaki
    Santoro, Cristina
    Michel, Marc
    Laborde, Serge
    Lovrencic, Barbara
    Hou, Ming
    Bailey, Tom
    Taylor-Stokes, Gavin
    Haenig, Jens
    Bussel, James B.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (02) : 199 - 207
  • [4] Cost and mortality associated with hospitalizations in patients with immune thrombocytopenic purpura
    Danese, Mark D.
    Lindquist, Karla
    Gleeson, Michelle
    Deuson, Robert
    Mikhael, Joseph
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2009, 84 (10) : 631 - 635
  • [5] Models for the analysis of repeated continuous outcome measures in clinical trials
    De Livera, Alysha M.
    Zaloumis, Sophie
    Simpson, Julie A.
    [J]. RESPIROLOGY, 2014, 19 (02) : 155 - 161
  • [6] Health-related quality of life and burden of fatigue in patients with primary immune thrombocytopenia by phase of disease
    Efficace, Fabio
    Mandelli, Franco
    Fazi, Paola
    Santoro, Cristina
    Gaidano, Gianluca
    Cottone, Francesco
    Borchiellini, Alessandra
    Carpenedo, Monica
    Simula, Maria Pina
    Di Giacomo, Valeria
    Bergamaschi, Micaela
    Vincelli, Iolanda Donatella
    Rodeghiero, Francesco
    Ruggeri, Marco
    Scaramucci, Laura
    Rambaldi, Alessandro
    Cascavilla, Nicola
    Forghieri, Fabio
    Petrungaro, Annamaria
    Ditonno, Paolo
    Caocci, Giovanni
    Cirrincione, Sonia
    Mazzucconi, Maria Gabriella
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2016, 91 (10) : 995 - 1001
  • [7] Idiopathic neutropenia of infancy: Data from the Italian Neutropenia Registry
    Farruggia, Piero
    Fioredda, Francesca
    Puccio, Giuseppe
    Onofrillo, Daniela
    Russo, Giovanna
    Barone, Angelica
    Bonanomi, Sonia
    Boscarol, Gianluca
    Finocchi, Andrea
    Ghilardi, Roberta
    Giordano, Paola
    Ladogana, Saverio
    Lassandro, Giuseppe
    Luti, Laura
    Lanza, Tiziana
    Mandaglio, Rosalba
    Marra, Nicoletta
    Martire, Baldassare
    Mastrodicasa, Elena
    Motta, Milena
    Notarangelo, Lucia Dora
    Pillon, Marta
    Porretti, Laura
    Serafinelli, Jessica
    Trizzino, Angela
    Tucci, Fabio
    Veltroni, Marinella
    Verzegnassi, Federico
    Ramenghi, Ugo
    Dufour, Carlo
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (02) : 216 - 222
  • [8] Patterns and influences in health-related quality of life in children with immune thrombocytopenia: A study from the Dallas ITP Cohort
    Flores, Adolfo
    Klaassen, Robert J.
    Buchanan, George R.
    Neunert, Cindy E.
    [J]. PEDIATRIC BLOOD & CANCER, 2017, 64 (08)
  • [9] Selective validation of the WHO Bleeding Scale in patients with chronic immune thrombocytopenia
    Fogarty, Patrick F.
    Tarantino, Michael D.
    Brainsky, Andres
    Signorovitch, James
    Grotzinger, Kelly M.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2012, 28 (01) : 79 - 87
  • [10] Current Management of the Hemophilic Child: A Demanding Interlocutor. Quality of Life and Adequate Cost-Efficacy Analysis
    Giordano, Paola
    Lassandro, Giuseppe
    Valente, Michele
    Molinari, Angelo Claudio
    Ierano, Paola
    Coppola, Antonio
    [J]. PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2014, 31 (08) : 687 - 702